MedTrace Logo

Pilot Test of a Mobile App That Helps Spanish-speakers Find Mental Health Services in the US.

NCT06619431 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2024-10-01

No results posted yet for this study

Summary

The goal of this observational study is to develop and test a mobile app for Spanish speakers residing in the US who seeking drug treatment and/or behavioral health services for themselves or an associate. The main questions it aims to answer are:

What are the features and content needed on this app?

How will people use and share this app?

Will they connect with treatment services?

After receiving input from focus group participants and other community stakeholders, the app was made available and its usage was tracked to determine its long-term, broad-scale feasibility.

Conditions

  • Health Disparity, Minority and Vulnerable Populations

Interventions

DEVICE

Mobile Application

"Rumbo" is an easily shared bi-lingual application that helps Hispanic individuals with unhealthy substance use find and access treatment services and related resources. The application stands out from other eHealth tools by leveraging the collective efficacy of the Hispanic community to overcome barriers and support individuals' self-efficacy for engaging the treatment system. Rumbo's simple, user-centered design provides less-acculturated Hispanic individuals with a culturally appropriate tool to understand their needs within the complex US treatment system. Rumbo is comprised of four innovations: (1) a sharing function that facilitates its own implementation among the target population; (2) culturally responsive content and design; (3) problem identification and treatment navigation enhanced to include related resources; (4) an API that is designed for interoperability across extant technologies.

Sponsors & Collaborators

  • Boston University

    collaborator OTHER

  • Pacific Institute for Research and Evaluation

    collaborator OTHER

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • National Institute on Drug Abuse (NIDA) (DA038095)

    collaborator UNKNOWN

  • Volver Health

    lead INDUSTRY

Principal Investigators

  • William P Campbell · Volver Health

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-04-02
Completion
2024-04-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06619431 on ClinicalTrials.gov